Published in Hospitalia, the hospital innovation magazine
Cleaning and disinfecting surfaces is a strategic issue for controlling cross-transmission and it has been highlighted more than ever by the health crisis. With its range of products that has been tried and tested for almost two decades, Oxy’Pharm demonstrates that it is possible to guarantee a healthy and controlled environment while also adopting an eco-responsible approach.
“Founded in 2003, Oxy’Pharm is a French SME that developed Nocotech, an innovative hydrogen peroxide-based concept for airborne surface disinfection (ASD). This process, which operates without the presence of a human, diffuses liquid disinfectants in the form of a dry mist, therefore ensuring that they are distributed in a homogeneous manner on all the surfaces of a room, even the least accessible ones,”explains Romain Rouleau, the Managing Director of Oxy’Pharm. This technology, which is now exported to 115 countries, is effective against bacteria, viruses, fungi, yeast and spores, in compliance with the requirements of European standard EN 17272. Its 100% biodegradable formula is also non-allergenic, non-corrosive – even for electronic equipment – and environmentally friendly. “At the end of 2019, we acquired Sanivap, the French specialist in steam bio-cleaning, whose solutions are certified according to the NF T72-110 standard. We can therefore offer a global range of products for eco-cleaning and eco-disinfection of surfaces are offered, and they are highly effective against all pathogens, including human coronaviruses,” he adds. Combining two complementary technologies immediately led to concrete applications in health care institutions.
The solutions were put to the test again during the Covid crisis
At Chartres Hospital, for example, it is used to disinfect rooms where Covid+ or scabies-positive patients or residents have stayed. “This cleaning method controls the risk of surface transmission by ensuring that all equipment and furniture in the room is disinfected. After initially cleaning with the Sanivap steam device, we then open the drawers, cupboard doors and toilet doors”to carry out a treatment using the Nocotech process, explains Barbara Acedo, the establishment’s hygiene manager. “With a setting that is accessible to all, we can ensure that patients can stay without the risk of surface transmission, while relieving the fears of teams working in a contaminated environment,” she continues.
At the Saint-Gaudens Hospital, near Toulouse, rooms in which Covid+ patients have stayed are also systematically treated with the Sanivap/Nocotech combination. “All surfaces are therefore disinfected without using toxic or corrosive products,” points out Dr Josyane Navarre, a hygienist.“The Covid crisis saw the start of numerous processes whose benefit-risk ratios are sometimes questionable. The effectiveness and safety of our solutions have been proven for 17 years for Nocotech and 25 years for Sanivap. This is certainly a strong argument, since we have been highly solicited in recent months by institutions all across the world,”concludes Romain Rouleau.
More information: www.oxypharm.net